Get the Stockscreener App
27.26
1.15%
0.31
Pre-market:
27.25
-0.01
-0.04%
Staar Surgical Co stock is traded at $27.26, with a volume of 2.38M.
It is up +1.15% in the last 24 hours and up +61.21% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$26.95
Open:
$27.1
24h Volume:
2.38M
Relative Volume:
1.56
Market Cap:
$1.35B
Revenue:
$341.22M
Net Income/Loss:
$21.78M
P/E Ratio:
61.95
EPS:
0.44
Net Cash Flow:
$26.30M
1W Performance:
+53.49%
1M Performance:
+61.21%
6M Performance:
+24.19%
1Y Performance:
-32.46%
1-Day Range:
$27.10
$27.47
1-Week Range:
$17.59
$27.47
52-Week Range:
$13.50
$40.81
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
27.26 | 1.32B | 341.22M | 21.78M | 26.30M | 0.44 |
|
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
11 Best Short-Term Stocks to Invest in - Insider Monkey
STAAR Surgical's largest holder demands books, records on Alcon deal (update) (STAA:NASDAQ) - Seeking Alpha
Shareholder Alert: The Ademi Firm Investigates Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders - Bluefield Daily Telegraph
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of STAAR Surgical Company (NASDAQ: STAA) - Benzinga
Alcon announces purchase of STARR Surgical for $1.5 billion - MSN
This Campbell's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
STAAR Surgical Q2 2025 net sales down 55% to USD 44.3M - Medical Buyer
Staar Surgical: Q2 Earnings Snapshot - New Haven Register
Alcon to acquire STAAR Surgical for $1.5B, sharpening focus on vision surgery - Tech Funding News
Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition By Investing.com - Investing.com Australia
Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition - Investing.com
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
STAAR Surgical (NASDAQ:STAA) Delivers Strong Q2 Numbers - uk.finance.yahoo.com
STAAR Surgical earnings beat by $0.22, revenue topped estimates - Investing.com Australia
STAAR Surgical Earnings: China Sales Plunge 55%, But Global Markets Show 10% Growth in Latest Quarter - Stock Titan
Alcon agrees to acquire STAAR Surgical - Optometry Times
Switzerland: Alcon to acquire STAAR Surgical for US$1.5bn - Investors in Healthcare
Alcon to Acquire STAAR Surgical in $1.5 Billion Deal - The Globe and Mail
Alcon to acquire STAAR Surgical - Medical Buyer
Alcons 260 Drop Amid 300M Volume Surge Ranks 409th as 15B STAAR Acquisition Drives Strategic Expansion - AInvest
Bright move: Alcon offers $1.5B for Staar Surgical - BioWorld MedTech
Why Are STAAR Surgical (STAA) Shares Soaring Today - uk.finance.yahoo.com
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical - GlobeNewswire
Gibson Dunn, Wachtell Advise On $1.5B Vision Implant Deal - Law360
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB), Couchbase, Inc. (Nasdaq – BASE), Core Scientific, Inc. (Nasdaq - GlobeNewswire Inc.
STAAR Surgical stock rating downgraded to Neutral by Sidoti on Alcon deal - Investing.com
STAAR Surgical stock price target raised to $28 from $20 at Canaccord - Investing.com Nigeria
Alcon to Acquire Staar Surgical for $1.5B - Orange County Business Journal
The Ademi Firm Investigates Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders - 富途牛牛
Eyecare company with Berks locations announces acquisition - WFMZ.com
Top 2 Health Care Stocks You May Want To Dump In Q3 - 富途牛牛
Staar Surgical Co (STAA) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
STAAR Surgical stock soars after Alcon announces $1.5B acquisition By Investing.com - Investing.com South Africa
STAAR Surgical stock soars after Alcon announces $1.5B acquisition - Investing.com
Why Is STAAR Surgical Stock Skyrocketing Tuesday?Alcon (NYSE:ALC), Staar Surgical (NASDAQ:STAA) - Benzinga
Alcon to Buy STAAR Surgical for $1.5 Billion - Medical Product Outsourcing
First Look: PG&E Surges, Intel Downgraded, and Alcon Acquires ST - GuruFocus
STAA to Be Acquired by Alcon for $28 Cash Per Share in Definitive Deal | STAA SEC FilingForm 8-K - Stock Titan
STAAR Surgical to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025 - The Globe and Mail
Alcon to acquire Staar Surgical in $1.5B deal - MassDevice
Alcon strikes $1.5bn deal to acquire ailing rival STAAR Surgical - Yahoo Finance
Alcon Buys STAAR Surgical To Expand Eye Care Portfolio - Finimize
Why STAAR Surgical Company stock attracts strong analyst attentionSector-Wise Stock Strength Trend Analysis - Newser
Alcon Agrees to Acquire STAAR Surgical - BioSpace
'Autofocus' specs promise sharp vision, near or far - AOL.com
Alcon to buy eye health firm STAAR Surgical for $1.5 bln - Investing.com
STAAR Surgical Company stock chart pattern explainedROI Focused Setup Screener With Exit Markers - Newser
STAAR Surgical Co expected to post a loss of 65 cents a shareEarnings Preview - TradingView
Is STAAR Surgical Company meeting your algorithmic filter criteriaSafe Entry Zone Based on Chart Analysis - Newser
Is STAAR Surgical Company stock a growth or value playFree Risk Managed Intraday Trade Alerts - Newser
What are analysts’ price targets for STAAR Surgical Company in the next 12 monthsSuperior capital gains - Jammu Links News
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):